Synthesis and antihypertensive activity of 4-(substituted-carbonylamino)-2H-1-benzopyrans
- 1 September 1990
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 33 (9) , 2667-2672
- https://doi.org/10.1021/jm00171a051
Abstract
The synthesis and antihypertensive activity of a series of novel 4-(substituted-carbonylamino)-2H-1-benzopyran-3-ols, administered orally to conscious spontaneously hypertensive rats, are described. Optimum activity was observed for compounds with alkyl, amino, or aryl groups flanking the carbonyl group. Of the alkyl and amino series the most potent compounds contained the methyl and methylamino groups, respectively. Several analogues have been compared with cromakalim (1) for their effects on potassium ion efflux in the rabbit mesenteric artery using rubidium-86 as a marker. The ability of each compound to enhance rubidium-86 efflux is approximately paralleled by its blood pressure lowering activity, and thus these analogues, like compound (1), belong to the series of drugs which have been classified as potassium-channel activators.This publication has 2 references indexed in Scilit:
- Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activatorBiochemical Pharmacology, 1987
- Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal veinBritish Journal of Pharmacology, 1986